# Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4

> **NCT00000329** · PHASE2 · WITHDRAWN · sponsor: **University of Colorado, Denver**

## Conditions studied

- Heroin Dependence
- Opioid-Related Disorders

## Interventions

- **DRUG:** Opioid-Related Disorders

## Key facts

- **NCT ID:** NCT00000329
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 1999-04
- **Primary completion:** 1999-08
- **Final completion:** 1999-08
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000329, "Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*